Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Characterization of HMGB1/2 Interactome in Prostate Cancer by Yeast Two Hybrid Approach: Potential Pathobiological Implications.

Barreiro-Alonso A, Cámara-Quílez M, Salamini-Montemurri M, Lamas-Maceiras M, Vizoso-Vázquez Á, Rodríguez-Belmonte E, Quindós-Varela M, Martínez-Iglesias O, Figueroa A, Cerdán ME.

Cancers (Basel). 2019 Nov 5;11(11). pii: E1729. doi: 10.3390/cancers11111729.

2.

In Vitro Anti-proliferative and Anti-invasive Effect of Polysaccharide-rich Extracts from Trametes Versicolor and Grifola Frondosa in Colon Cancer Cells.

Roca-Lema D, Martinez-Iglesias O, Fernández de Ana Portela C, Rodríguez-Blanco A, Valladares-Ayerbes M, Díaz-Díaz A, Casas-Pais A, Prego C, Figueroa A.

Int J Med Sci. 2019 Jan 1;16(2):231-240. doi: 10.7150/ijms.28811. eCollection 2019.

3.

Hakai overexpression effectively induces tumour progression and metastasis in vivo.

Castosa R, Martinez-Iglesias O, Roca-Lema D, Casas-Pais A, Díaz-Díaz A, Iglesias P, Santamarina I, Graña B, Calvo L, Valladares-Ayerbes M, Concha Á, Figueroa A.

Sci Rep. 2018 Feb 22;8(1):3466. doi: 10.1038/s41598-018-21808-w.

4.

Proteomic Analysis of the E3 Ubiquitin-Ligase Hakai Highlights a Role in Plasticity of the Cytoskeleton Dynamics and in the Proteasome System.

Díaz-Díaz A, Casas-Pais A, Calamia V, Castosa R, Martinez-Iglesias O, Roca-Lema D, Santamarina I, Valladares-Ayerbes M, Calvo L, Chantada V, Figueroa A.

J Proteome Res. 2017 Aug 4;16(8):2773-2788. doi: 10.1021/acs.jproteome.7b00046. Epub 2017 Jul 21.

PMID:
28675930
5.

The nuclear corepressor 1 and the thyroid hormone receptor β suppress breast tumor lymphangiogenesis.

Martínez-Iglesias O, Olmeda D, Alonso-Merino E, Gómez-Rey S, González-López AM, Luengo E, Soengas MS, Palacios J, Regadera J, Aranda A.

Oncotarget. 2016 Nov 29;7(48):78971-78984. doi: 10.18632/oncotarget.12978.

6.

Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses.

Alonso-Merino E, Martín Orozco R, Ruíz-Llorente L, Martínez-Iglesias OA, Velasco-Martín JP, Montero-Pedrazuela A, Fanjul-Rodríguez L, Contreras-Jurado C, Regadera J, Aranda A.

Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):E3451-60. doi: 10.1073/pnas.1506113113. Epub 2016 May 31.

7.

Tumor suppressive actions of the nuclear receptor corepressor 1.

Martínez-Iglesias O, Alonso-Merino E, Aranda A.

Pharmacol Res. 2016 Jun;108:75-79. doi: 10.1016/j.phrs.2016.04.027. Epub 2016 May 2.

PMID:
27149915
8.

Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis.

Martínez-Iglesias OA, Alonso-Merino E, Gómez-Rey S, Velasco-Martín JP, Martín Orozco R, Luengo E, García Martín R, Ibáñez de Cáceres I, Fernández AF, Fraga MF, González-Peramato P, Varona C, Palacios J, Regadera J, Aranda A.

Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E328-37. doi: 10.1073/pnas.1520469113. Epub 2016 Jan 4.

9.

microRNAs 424 and 503 are mediators of the anti-proliferative and anti-invasive action of the thyroid hormone receptor beta.

Ruiz-Llorente L, Ardila-González S, Fanjul LF, Martínez-Iglesias O, Aranda A.

Oncotarget. 2014 May 30;5(10):2918-33.

10.

The thyroid hormone receptors as tumor suppressors.

Ruiz-Llorente L, Martínez-Iglesias O, García-Silva S, Tenbaum S, Regadera J, Aranda A.

Horm Mol Biol Clin Investig. 2011 Mar 1;5(2):79-89. doi: 10.1515/HMBCI.2010.045.

PMID:
25961243
11.

Residues K128, 132, and 134 in the thyroid hormone receptor-alpha are essential for receptor acetylation and activity.

Sánchez-Pacheco A, Martínez-Iglesias O, Méndez-Pertuz M, Aranda A.

Endocrinology. 2009 Nov;150(11):5143-52. doi: 10.1210/en.2009-0117. Epub 2009 Oct 9.

12.

Thyroid receptor: roles in cancer.

Aranda A, Martínez-Iglesias O, Ruiz-Llorente L, García-Carpizo V, Zambrano A.

Trends Endocrinol Metab. 2009 Sep;20(7):318-24. doi: 10.1016/j.tem.2009.03.011. Epub 2009 Aug 26. Review.

PMID:
19716314
13.

Hypothyroidism enhances tumor invasiveness and metastasis development.

Martínez-Iglesias O, García-Silva S, Regadera J, Aranda A.

PLoS One. 2009 Jul 29;4(7):e6428. doi: 10.1371/journal.pone.0006428.

14.

Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis.

Martínez-Iglesias O, Garcia-Silva S, Tenbaum SP, Regadera J, Larcher F, Paramio JM, Vennström B, Aranda A.

Cancer Res. 2009 Jan 15;69(2):501-9. doi: 10.1158/0008-5472.CAN-08-2198.

15.

Anti-estrogenic actions of histone deacetylase inhibitors in MCF-7 breast cancer cells.

De los Santos M, Martínez-Iglesias O, Aranda A.

Endocr Relat Cancer. 2007 Dec;14(4):1021-8.

PMID:
18045953
16.

A permissive retinoid X receptor/thyroid hormone receptor heterodimer allows stimulation of prolactin gene transcription by thyroid hormone and 9-cis-retinoic acid.

Castillo AI, Sánchez-Martínez R, Moreno JL, Martínez-Iglesias OA, Palacios D, Aranda A.

Mol Cell Biol. 2004 Jan;24(2):502-13.

Supplemental Content

Loading ...
Support Center